PHX Energy Services Corp. - PHX.TO

PHX.TO Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
PHX.TO	-1.6	-2.1	-2.3	-9.8	4.2	4.9	102.1	258.2	-18.8	1077.5
S&P 500	-1.3	-1.9	0.1	5.7	10.7	29.1	24.8	88.0	186.1	33142.5

Compare PHX.TO with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	PHX.TO
name	PHX Energy Services Corp.
price	9.42
changes percentage	-1.57
change	-0.15
day low	9.40
day high	9.57
year high	10.70
year low	7.91
market cap	429440844
price avg 50	9.50
price avg 200	9.36
exchange	TSX
volume	31197
avg volume	84671
open	9.57
previous close	9.57
eps	1.54
pe	6.12
earnings announcement	2025-02-25T10:00:00.000+0000
shares outstanding	45588200
timestamp	2024-11-15 21:00:00

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 68.0%

Overall Quarterly Financial Health: 41.7%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	656341000	535744879	22.51
gross profit	150105000	109638308	36.91
gross profit ratio	0.23	0.2	11.75
research and development expenses	5210000	3722513	39.96
operating expenses	74125000	72623717	2.07
interest income	0	3391978	-100.00
interest expense	4667000	3391978	37.59
ebitda	150076000	72880428	105.92
ebitdaratio	0.23	0.14	68.08
operating income	75980000	37526898	102.47
operating income ratio	0.12	0.07	65.27
net income	98580000	44311390	122.47
net income ratio	0.15	0.08	81.59
eps	1.98	0.88	125.00

Overall Score of Annual Income Statement

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 656 million in 2023 from 536 million in 2022 representing a change of 22.51%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 150 million in 2023 from 110 million in 2022 representing a change of 36.91%. This indicates a sales profitability growth, which is a positive sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses increased to 5 million in 2023 from 4 million in 2022 representing a change of 39.96%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Income: Operating income increased to 76 million in 2023 from 38 million in 2022 representing a change of 102.47%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 99 million in 2023 from 44 million in 2022 representing a change of 122.47%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 1.98 in 2023 from 1.98 in 2022 representing a change of 125.0%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• 📉 Negative Indicators

  Operating Expenses: Operating Expenses increased to 74 million in 2023 from 73 million in 2022 representing a change of 2.07%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to 150 million in 2023 from 73 million in 2022 representing a change of 105.92%. The decrease in EBITDA indicates declined operational efficiency and profitability.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
revenue	160634000	154230000	4.15
gross profit	28968000	27774000	4.30
gross profit ratio	0.18	0.18	0.14
research and development expenses	1392000	1409000	-1.21
operating expenses	17277000	15233000	13.42
interest income	0	0	NaN
interest expense	1248000	531000	135.03
ebitda	28925000	24540000	17.87
ebitdaratio	0.18	0.16	13.17
operating income	11691000	12541000	-6.78
operating income ratio	0.07	0.08	-10.49
net income	10160000	12913000	-21.32
net income ratio	0.06	0.08	-24.46
eps	0.22	0.27	-18.52

Overall Score of Quarterly Income Statement

0.38 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 161 million in 2024Q3 from 154 million in 2024Q2 representing a change of 4.15%. This indicates a sales growth, which is a positive sign for the company.

  Gross Profit: Gross Profit increased to 29 million in 2024Q3 from 28 million in 2024Q2 representing a change of 4.3%. This indicates a sales profitability growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 29 million in 2024Q3 from 25 million in 2024Q2 representing a change of 17.87%. The increase in EBITDA indicates improved operational efficiency and profitability.

• 📉 Negative Indicators

  Research and Development (R&D) Expenses: R&D Expenses decreased to 1 million in 2024Q3 from 1 million in 2024Q2 representing a change of -1.21%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 17 million in 2024Q3 from 15 million in 2024Q2 representing a change of 13.42%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  Operating Income: Operating income decreased to 12 million in 2024Q3 from 13 million in 2024Q2 representing a change of -6.78%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to 10 million in 2024Q3 from 13 million in 2024Q2 representing a change of -21.32%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

  Earnings per Share (EPS): EPS increased to 0.22 in 2024Q3 from 0.22 in 2024Q2 representing a change of -18.52%. This indicates that the company's earnings are decreasing and it is becoming less profitable on a per-share basis.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	385494000	375224188	2.74
total liabilities	175525000	198345735	-11.51
total equity	209969000	176878453	18.71
cash and cash equivalents	16433000	18247376	-9.94
short term investments	0	0	NaN
long term investments	3001000	3000500	0.02
total current assets	207040000	210227304	-1.52
total non current assets	178454000	164996884	8.16
total current liabilities	113125000	115888193	-2.38
total non current liabilities	62400000	82457542	-24.32
common stock	222653000	251344809	-11.42
retained earnings	-45695000	-112120484	59.24
total debt	44770000	62406100	-28.26

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 385 million in 2023 from 375 million in 2022 representing a change of 2.74%. Suggesting a growth in asset holdings.

  Total Liabilities: Total Liabilities decreased to 176 million in 2023 from 198 million in 2022 representing a change of -11.51%. This indicates a decrease in overall liabilities.

  Total Equity: Total Equity increased to 210 million in 2023 from 177 million in 2022 representing a change of 18.71%. This indicates an increase in shareholders' equity.

  Total Current Liabilities: Total Current Liabilities decreased to 113 million in 2023 from 116 million in 2022 representing a change of -2.38%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to -46 million in 2023 from -112 million in 2022 representing a change of 59.24%. This indicates an accumulated profits.

  Total Debt: Total Debt decreased to 45 million in 2023 from 62 million in 2022 representing a change of -28.26%. This indicates a reduction in overall debt burden.

• 📉 Negative Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents decreased to 16 million in 2023 from 18 million in 2022 representing a change of -9.94%. This indicates a decrease in available liquid assets.

  Total Current Assets: Total Current Assets decreased to 207 million in 2023 from 210 million in 2022 representing a change of -1.52%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 223 in 2023 from 251 in 2022 representing a change of -11.42%. This indicates a decrease in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
total assets	395414000	409373000	-3.41
total liabilities	185201000	185502000	-0.16
total equity	210213000	223871000	-6.10
cash and cash equivalents	14203000	13798000	2.94
short term investments	0	0	NaN
long term investments	2171000	2171000	0.00
total current assets	188562000	196435000	-4.01
total non current assets	206851999	212938000	-2.86
total current liabilities	112885000	121383000	-7.00
total non current liabilities	72315999	64119000	12.78
common stock	208093000	220633000	-5.68
retained earnings	-33286000	-34264000	2.85
total debt	54629000	45919000	18.97

Overall Score of Quarterly Balance Sheet

0.44 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 395 million in 2024Q3 from 409 million in 2024Q2 representing a change of -3.41%. Suggesting a decrease in asset holdings.

  Total Equity: Total Equity decreased to 210 million in 2024Q3 from 224 million in 2024Q2 representing a change of -6.1%. This indicates a decrease in shareholders' equity.

  Total Current Assets: Total Current Assets decreased to 189 million in 2024Q3 from 196 million in 2024Q2 representing a change of -4.01%. This indicates a worsen liquidity position.

  Common Stock: Common Stock decreased to 208 in 2024Q3 from 221 in 2024Q2 representing a change of -5.68%. This indicates a decrease in ownership interest.

  Total Debt: Total Debt increased to 55 million in 2024Q3 from 46 million in 2024Q2 representing a change of 18.97%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Total Liabilities: Total Liabilities decreased to 185 million in 2024Q3 from 186 million in 2024Q2 representing a change of -0.16%. This indicates a decrease in overall liabilities.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 14 million in 2024Q3 from 14 million in 2024Q2 representing a change of 2.94%. This indicates an increase in available liquid assets.

  Total Current Liabilities: Total Current Liabilities decreased to 113 million in 2024Q3 from 121 million in 2024Q2 representing a change of -7.0%. This indicates a lower short-term debt burden.

  Retained Earnings: Retained Earnings increased to -33 million in 2024Q3 from -34 million in 2024Q2 representing a change of 2.85%. This indicates an accumulated profits.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	-1814000	-6581454	72.44
operating cash flow	96723000	37082843	160.83
free cash flow	31105001	-37703608	182.50
capital expenditure	-65617999	-74786451	12.26
depreciation and amortization	41759000	35353530	18.12
deferred income tax	-5365000	9041530	-159.34
stock based compensation	491000	25019000	-98.04
accounts payables	-4669000	27478000	-116.99
inventory	0	-26919000	100.00
acquisitions net	0	27458977	-100.00
investments in property plant and equipment	-64932000	-74786451	13.18
net cash used for investing activites	-20262000	-47388193	57.24
debt repayment	-17744000	22731389	-178.06
common stock issued	964000	0	NaN
common stock repurchased	-30978000	-4110000	-653.72
dividends paid	-30189000	-15147530	-99.30
net cash used provided by financing activities	-77947000	2706092	-2,980.43
cash at end of period	16433000	18247376	-9.94
accounts receivables	4386000	-47647000	109.21
cash at beginning of period	18247000	24828830	-26.51

Overall Score of Annual Cashflow Statement

0.62 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to -2 million in 2023 from -7 million in 2022 representing a change of 72.44%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to 97 million in 2023 from 37 million in 2022 representing a change of 160.83%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 31 million in 2023 from -38 million in 2022 representing a change of 182.5%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2023 from 25 million in 2022 representing a change of -98.04%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Accounts Payables: The absolute value of Accounts Payables decreased to 5 million in 2023 from 27 million in 2022 representing a change of -116.99%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to -66 million in 2023 from -75 million in 2022 representing a change of 12.26%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Receivables: Accounts Receivables increased to 4 in 2023 from -48 million in 2022 representing a change of 109.21%. This suggests that the company is less capable of collecting payments from its customers.

  Dividends Paid: Dividends Paid decreased to -30 million in 2023 from -15 million in 2022 representing a change of -99.3%. This indicates a weaker financial position, less confidence in future prospects, and a reluctance to return value to shareholders.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q3	2024Q2	Q/Q change %
0000000000
operating cash flow	28741000	39317000	-26.90
free cash flow	17598000	12537000	40.37
capital expenditure	-11143000	-26780000	58.39
depreciation and amortization	12730000	11999000	6.09
deferred income tax	4787000	-4195000	214.11
stock based compensation	140000	1584000	-91.16
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	6973000	7409000	-5.88
investments in property plant and equipment	-12508000	-26780000	53.29
net cash used for investing activites	-14895000	-27658000	46.15
debt repayment	9500000	2060000	361.17
common stock issued	0	109000	-100.00
common stock repurchased	-12613000	-3143000	-301.30
dividends paid	-9437000	-9498000	0.64
net cash used provided by financing activities	-13306000	-11337000	-17.37
net change in cash	405000	418000	-3.11
cash at end of period	14203000	13798000	2.94
cash at beginning of period	13798000	13380000	3.12

Overall Score of Quarterly Cashflow Statement

0.43 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2024Q3 from 0 million in 2024Q2 representing a change of -3.11%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 29 million in 2024Q3 from 39 million in 2024Q2 representing a change of -26.9%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to -11 million in 2024Q3 from -27 million in 2024Q2 representing a change of 58.39%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Deferred Income Tax: Deferred Income Tax increased to 5 million in 2024Q3 from -4 million in 2024Q2 representing a change of 214.11%. This indicates that the company's tax liability for future periods has increased.

• 📈 Positive Indicators

  Free Cash Flow: Free Cash Flow increased to 18 million in 2024Q3 from 13 million in 2024Q2 representing a change of 40.37%. This indicates an increase in cash generated after accounting for capital expenditures.

  Stock-Based Compensation: Stock-Based Compensation decreased to 0 million in 2024Q3 from 2 million in 2024Q2 representing a change of -91.16%. This indicates decreased expenses, which is generally considered a positive sign from a financial perspective.

  Dividends Paid: Dividends Paid increased to -9 million in 2024Q3 from -9 million in 2024Q2 representing a change of 0.64%. This indicates a stronger financial position, more confidence in future prospects, and a better commitment to returning value to shareholders.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	13.18	10.68	23.39
net income per share	1.98	0.88	124.06
operating cash flow per share	1.94	0.74	162.70
free cash flow per share	0.62	-0.75	183.09
cash per share	0.33	0.36	-9.30
book value per share	4.22	3.53	19.56
tangible book value per share	3.93	3.21	22.31
shareholders equity per share	4.22	3.53	19.56
interest debt per share	0.25	0.52	-52.84
market cap	403281819.9	389621475.18	3.51
enterprise value	431618819.9	433780199.18	-0.50
pe ratio	4.09	8.79	-53.47
price to sales ratio	0.61	0.73	-15.51
pocfratio	4.17	10.51	-60.32
pfcf ratio	12.97	-10.33	225.46
pb ratio	1.92	2.2	-12.81
ptb ratio	1.92	2.2	-12.81
ev to sales	0.66	0.81	-18.78
enterprise value over ebitda	2.88	5.95	-51.68
ev to operating cash flow	4.46	11.7	-61.85
ev to free cash flow	13.88	-11.51	220.61
earnings yield	0.24	0.11	114.94
free cash flow yield	0.08	-0.1	179.70
debt to equity	0.04	0.13	-71.97
debt to assets	0.02	0.06	-67.61
net debt to ebitda	0.19	0.61	-68.84
current ratio	1.83	1.81	0.89
interest coverage	16.28	11.06	47.15
income quality	0.98	0.84	17.24
dividend yield	0.07	0.04	92.55
payout ratio	0.31	0.34	-10.42
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.01	0.01	14.24
intangibles to total assets	0.04	0.04	-11.78
capex to operating cash flow	0.68	2.02	-66.36
capex to revenue	0.1	0.14	-28.38
capex to depreciation	1.57	2.12	-25.72
stock based compensation to revenue	0.0	0.05	-98.40
graham number	13.71	8.37	63.67
roic	0.33	0.16	112.75
return on tangible assets	0.27	0.12	115.44
graham net net	-0.68	-1.08	37.26
working capital	93915000	94339111	-0.45
tangible asset value	195769000	161210453	21.44
net current asset value	31515000	11881569	165.24
invested capital	263434000	255288111	3.19
average receivables	125430636.5	101330460	23.78
average payables	95914829	82687028.5	16.00
average inventory	63146244.5	49905315	26.53
days sales outstanding	69.53	85.73	-18.90
days payables outstanding	70.86	80.14	-11.58
days of inventory on hand	45.55	54.07	-15.76
receivables turnover	5.25	4.26	23.30
payables turnover	5.15	4.55	13.09
inventory turnover	8.01	6.75	18.70
roe	0.47	0.25	87.41
capex per share	1.32	1.49	-11.63

• Positive

  ROE: Return on Equity (ROE) increased to 0.47 on 2023-12-31 from 0.25 on 2022-12-31, representing a change of 87.41%. Suggesting the company has been generating high returns for its shareholders.

  Current Ratio: Current Ratio increased to 1.83 on 2023-12-31 from 1.81 on 2022-12-31, representing a change of 0.89%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.04 on 2023-12-31 from 0.13 on 2022-12-31, representing a change of -71.97%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 4.09 on 2023-12-31 from 8.79 on 2022-12-31, representing a change of -53.47%. Indicating a decrease in the relative valuation of the company's stock.

• Quarterly Financial Ratios

	2024-09-30 Q3	2024-06-30 Q2	Q/Q change %
PHX.TO
calendar year	2024	2024	NaN
revenue per share	3.48	3.27	6.40
net income per share	0.22	0.27	-19.62
operating cash flow per share	0.62	0.83	-25.32
free cash flow per share	0.38	0.27	43.40
cash per share	0.31	0.29	5.16
book value per share	4.55	4.75	-4.07
tangible book value per share	4.25	4.46	-4.85
shareholders equity per share	4.55	4.75	-4.07
interest debt per share	0.44	0.22	104.91
market cap	419330907.44	427919924.35	-2.01
enterprise value	459756907.44	460040924.35	-0.06
pe ratio	10.32	8.28	24.55
price to sales ratio	2.61	2.77	-5.91
pocfratio	14.59	10.88	34.05
pfcf ratio	23.83	34.13	-30.19
pb ratio	1.99	1.91	4.36
ptb ratio	1.99	1.91	4.36
ev to sales	2.86	2.98	-4.05
enterprise value over ebitda	15.89	18.75	-15.21
ev to operating cash flow	16.0	11.7	36.71
ev to free cash flow	26.13	36.69	-28.80
earnings yield	0.02	0.03	-19.71
free cash flow yield	0.04	0.03	43.24
debt to equity	0.09	0.04	111.59
debt to assets	0.05	0.02	105.70
net debt to ebitda	1.4	1.31	6.78
current ratio	1.67	1.62	3.22
interest coverage	9.37	23.62	-60.34
income quality	2.83	3.04	-7.09
dividend yield	0.02	0.02	1.39
payout ratio	0.93	0.74	26.28
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.01	0.01	-5.15
intangibles to total assets	0.04	0.03	9.73
capex to operating cash flow	0.39	0.68	-43.08
capex to revenue	0.07	0.17	-60.05
capex to depreciation	0.88	2.23	-60.78
stock based compensation to revenue	0.0	0.01	-91.51
graham number	4.75	5.41	-12.19
roic	0.03	0.04	-16.15
return on tangible assets	0.03	0.03	-18.28
graham net net	-1.26	-1.14	-10.59
working capital	75677000	75052000	0.83
tangible asset value	196125000	210579000	-6.86
net current asset value	3361000	10933000	-69.26
invested capital	273192000	276421000	-1.17
average receivables	111205500	121214000	-8.26
average payables	98493000	99580157.5	-1.09
average inventory	63911000	63365000	0.86
days sales outstanding	60.32	66.97	-9.93
days payables outstanding	64.19	73.37	-12.52
days of inventory on hand	43.81	45.36	-3.40
receivables turnover	1.49	1.34	11.02
payables turnover	1.4	1.23	14.31
inventory turnover	2.05	1.98	3.52
roe	0.05	0.06	-16.21
capex per share	0.24	0.57	-57.49

• Negative

  ROE: Return on Equity (ROE) decreased to 0.05 on 2024-09-30 Q3 from 0.06 on 2024-06-30 Q2, representing a change of -16.21%. Suggesting that the company has not been generating high returns for its shareholders.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 10.32 on 2024-09-30 Q3 from 8.28 on 2024-06-30 Q2, representing a change of 24.55%. Indicating an increase in the relative valuation of the company's stock.

  Current Ratio: Current Ratio increased to 1.67 on 2024-09-30 Q3 from 1.62 on 2024-06-30 Q2, representing a change of 3.22%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to 0.09 on 2024-09-30 Q3 from 0.04 on 2024-06-30 Q2, representing a change of 111.59%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

Negative Sentiment: Discounted Cash Flow value is 8.52 which is lower than current price 9.42, indicates the company may be overvalued.